The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical impact of comprehensive versus targeted genomic analysis for precision oncology.
 
Mario Lamping
No Relationships to Disclose
 
Damian Tobias Rieke
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Alacris Theranostics
 
Frederick Klauschen
No Relationships to Disclose
 
Korinna Jöhrens
No Relationships to Disclose
 
Ioannis Anagnostopoulos
Consulting or Advisory Role - AstraZeneca
Research Funding - Bristol-Myers Squibb
 
Dido Lenze
Employment - AstraZeneca; AstraZeneca (I)
 
Inge Tinhofer
Consulting or Advisory Role - Merck Serono
 
Manuela Benary
No Relationships to Disclose
 
Sebastian Ochsenreither
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ipsen; Merck; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Merck; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen
 
Konrad Friedrich Klinghammer
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono
 
Susen Burock
No Relationships to Disclose
 
Henning Jann
No Relationships to Disclose
 
Anna Kathrin Stüven
No Relationships to Disclose
 
Doreen Ditzen
No Relationships to Disclose
 
Dieter Beule
Stock and Other Ownership Interests - MicroDiscovery
Patents, Royalties, Other Intellectual Property - EP2781910; US20140286550
 
Clemens Messerschmidt
No Relationships to Disclose
 
Eric Blanc
No Relationships to Disclose
 
Reinhold Schäfer
Stock and Other Ownership Interests - Cellular Phenomics and Oncology
 
Ulrich Keilholz
Honoraria - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck KGaA; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; pfizer
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck Serono; MSD Oncology; Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Merck Serono; MSD Oncology